NCT04485819|Unknown
Optimal Embryonic Stage for Transfer in Poor Responders
Achieving Better Clinical Outcomes With Blastocyt Transfer in Poor Responders: a Prospective Study
Loading search results
Achieving Better Clinical Outcomes With Blastocyt Transfer in Poor Responders: a Prospective Study
Sponsor study identifier
observational
300
1 country
1
Study Start
January 1, 2019
Actual (reported)Primary Completion
December 1, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
March 1, 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
A Prospective cohort study including couples with poor responder females who undergoing ICSI
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 1, 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 1, 2019
Actual (reported)July 22, 2020
Actual (reported)July 24, 2020
Actual (reported)December 1, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
March 1, 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Live birth rate
percentage of cycles started with the intent of egg retrieval that led to a live birth.
delivery of healthy neonate after 37 weeks of pregnancy
Implantation rate
Percentage of the implanted embryos number for each group / number of transferred embryos.
6 weeks of pregnancy
Clinical pregnancy rate
after 6 weeks of embryonic transfer
Cancellation rate
5:6 days of ICSI
Fertilization rate
16:19 hours after intracytoplasmic injection(ICSI)
Cleavage rate
72 hours after ICSI
High quality day 3 embryos
72 hours after ICSI
Poor responders who transfer their embryos in cleavage stage on day 3
Poor responders who transfer their embryos on blast stage on day 5/6
transferring embryos through ICSI procedures for poor responders on cleavage stage of embryonic development.
transferring embryos through ICSI procedures for poor responders on blast stage of embryonic development.
Poor responders undergoing ICSI procedures at Ganin fertility center in Egypt
Ganin fertility center
Cairo, 11728, Egypt
Manar Hozyen, MSc.
Ganin Fertility Center
Amira Hassan, BSc.
Ganin Fertility Center
Hanaa Elkhader, BSc.
Ganin Fertility Center
Hosam Zaki
Ganin Fertility Center
First Submitted
July 22, 2020
First Posted
July 24, 2020
Study Start
January 1, 2019
Actual (reported)Primary Completion
December 1, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Effect of GH Administration in Poor Responders Undergoing Intracytoplasmic Sperm Injection (ICSI)
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Study Completion
March 1, 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
July 24, 2020
Record last verified: 2020-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: